天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

Home Cart 0 Sign in  

[ CAS No. 252882-61-4 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 252882-61-4
Chemical Structure| 252882-61-4
Structure of 252882-61-4 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 252882-61-4 ]

Related Doc. of [ 252882-61-4 ]

Alternatived Products of [ 252882-61-4 ]
Product Citations

Product Details of [ 252882-61-4 ]

CAS No. :252882-61-4 MDL No. :MFCD12198581
Formula : C12H14N2O Boiling Point : No data available
Linear Structure Formula :- InChI Key :SXOVJOBXZPCKRA-UHFFFAOYSA-N
M.W : 202.25 Pubchem ID :18435788
Synonyms :

Calculated chemistry of [ 252882-61-4 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 15
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.42
Num. rotatable bonds : 0
Num. H-bond acceptors : 2.0
Num. H-bond donors : 2.0
Molar Refractivity : 65.45
TPSA : 41.13 ?2

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : Yes
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : Yes
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.04 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.87
Log Po/w (XLOGP3) : 0.69
Log Po/w (WLOGP) : 0.31
Log Po/w (MLOGP) : 1.45
Log Po/w (SILICOS-IT) : 2.1
Consensus Log Po/w : 1.28

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.82
Solubility : 3.03 mg/ml ; 0.015 mol/l
Class : Very soluble
Log S (Ali) : -1.13
Solubility : 15.0 mg/ml ; 0.074 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -4.04
Solubility : 0.0183 mg/ml ; 0.0000906 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.19

Safety of [ 252882-61-4 ]

Signal Word:Warning Class:
Precautionary Statements:P261-P305+P351+P338 UN#:
Hazard Statements:H315-H319-H335 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 252882-61-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 252882-61-4 ]
  • Downstream synthetic route of [ 252882-61-4 ]

[ 252882-61-4 ] Synthesis Path-Upstream   1~3

  • 1
  • [ 1086063-19-5 ]
  • [ 252882-61-4 ]
YieldReaction ConditionsOperation in experiment
90.2% With hydrogen In methanol at 20℃; for 15 h; Process 1Production of spiro(indole-3,4'-piperidine)-2(1H)-oneSpiro(indole-3,4'-piperidine)-2(1H)-one was produced by the method described below.Under an argon atmosphere, a tetrahydrofuran solution (20 mL) of oxindole (3.00 g, 22.5 mmol) and a tetrahydrofuran solution (20 mL) of benzylbis(2-chloroethyl)amine (5.20 g, 22.5 mmol) were added sequentially to a tetrahydrofuran solution (100 mL) of sodium hydride (1.60 g, 67.6 mmol) at room temperature. The mixture was stirred at the same temperature for 1 hour and further stirred at 90° C. for 3 hours. The reaction solution was cooled to room temperature, and then added with a tetrahydrofuran solution (10 mL) of sodium hydride (0.540 g, 22.5 mmol) and stirred further at 90° C. for 12 hours. The reaction solution was added with saturated ammonium-chloride aqueous solution and stirred at room temperature for 10 minutes. The mixed solution was poured into the mixed solution of a saturated aqueous solution of sodium hydrogen carbonate and brine, then extracted with ethyl acetate. The organic layer was dried with anhydrous sodium sulfate, followed by a vacuum concentration. The resultant residue was purified by silica-gel chromatography (chloroform:methanol=20:1) and 1'-benzylspiro(indole-3,4'-piperidine)-2(1H)-one (2.94 g, 44.6percent) was obtained as a yellow amorphous solid.1H-NMR (400 MHz, CDCl3) δ; 1.78-1.93 (m, 2H), 1.95-2.06 (m, 2H), 2.65-2.77 (m, 2H), 2.87-3.00 (m, 2H), 3.69 (s, 2H), 6.90 (d, J=7.6 Hz, 1H), 7.02(t, J=7.6 Hz, 1H), 7.20 (t, J=7.6 Hz, 1H), 7.26 (t, J=6.2 Hz, 1H), 7.34 (t, J=7.6 Hz, 2H), 7.40-7.41(m, 3H), 8.72 (s, 1H).To a methanol solution (5 mL) of 1'-benzylspiro(indole-3,4'-piperidine)-2(1H)-one (300 mg, 1.03 mmol), 10percent palladium carbon (30.0 mg) was added. The mixture was stirred under a hydrogen atmosphere at room temperature for 15 hours. The reaction solution was filtered using celite followed by a vacuum concentration, and spiro(indole-3,4'-piperidine)-2(1H)-one (187 mg, 90.2percent) was obtained as a colorless amorphous solid.1H-NMR (400 MHz, CDCl3) δ; 1.73-1.78 (m, 2H), 1.88-1.94 (m, 2H), 3.06-3.12 (m, 2H), 3.35-3.41 (m, 2H), 6.92 (d, J=7.7 Hz, 1H), 7.04 (t, J=7.7 Hz, 1H), 7.22 (t, J=7.7 Hz, 1H), 7.42 (d, J=7.7 Hz, 1H), 8.70 (br, 1H).
78% With palladium 10% on activated carbon; hydrogen In methanol at 20℃; for 15 h; Step 2A solution of 1’-benzylspiro[indoline-3,4’-piperidin]-2-one 2a (5 g, 17.10 mmol, 1 eq.)in methanol (100 ml) was hydrogenated at RT with 10percent Pd/C (0.18 g) as a catalyst for15h. The catalyst was filtered off and the solvent was evaporated under vacuum. Theresidue was then recrystallized from DIPE/acetonitrile to give 2.7 g (78percent yield) of spiro [indoline-3 ,4’-piperidin] -2-one 2b.
Reference: [1] Patent: US2008/306102, 2008, A1, . Location in patent: Page/Page column 12
[2] ACS Medicinal Chemistry Letters, 2018, vol. 9, # 2, p. 94 - 97
[3] Patent: WO2014/60411, 2014, A1, . Location in patent: Page/Page column 36
  • 2
  • [ 252882-60-3 ]
  • [ 252882-61-4 ]
Reference: [1] Patent: WO2007/28638, 2007, A1, . Location in patent: Page/Page column 96
[2] Patent: US6172076, 2001, B2,
[3] Patent: WO2008/144266, 2008, A1, . Location in patent: Page/Page column 29
  • 3
  • [ 59-48-3 ]
  • [ 252882-61-4 ]
Reference: [1] Patent: US6172076, 2001, B2,
[2] Patent: WO2008/144266, 2008, A1,
[3] Patent: US2008/306102, 2008, A1,
Recommend Products
Same Skeleton Products

Technical Information

Historical Records

Related Functional Groups of
[ 252882-61-4 ]

Amides

Chemical Structure| 356072-46-3

[ 356072-46-3 ]

Spiro[indoline-3,4'-piperidin]-2-one hydrochloride

Similarity: 0.89

Chemical Structure| 79098-85-4

[ 79098-85-4 ]

3-(Piperidin-4-yl)indolin-2-one hydrochloride

Similarity: 0.89

Chemical Structure| 13861-75-1

[ 13861-75-1 ]

Spiro[cyclopropane-1,3'-indolin]-2'-one

Similarity: 0.87

Chemical Structure| 19155-24-9

[ 19155-24-9 ]

3,3-Dimethylindolin-2-one

Similarity: 0.87

Chemical Structure| 1504-06-9

[ 1504-06-9 ]

3-Methyloxindole

Similarity: 0.87

Related Parent Nucleus of
[ 252882-61-4 ]

Indolines

Chemical Structure| 356072-46-3

[ 356072-46-3 ]

Spiro[indoline-3,4'-piperidin]-2-one hydrochloride

Similarity: 0.89

Chemical Structure| 79098-85-4

[ 79098-85-4 ]

3-(Piperidin-4-yl)indolin-2-one hydrochloride

Similarity: 0.89

Chemical Structure| 13861-75-1

[ 13861-75-1 ]

Spiro[cyclopropane-1,3'-indolin]-2'-one

Similarity: 0.87

Chemical Structure| 19155-24-9

[ 19155-24-9 ]

3,3-Dimethylindolin-2-one

Similarity: 0.87

Chemical Structure| 1504-06-9

[ 1504-06-9 ]

3-Methyloxindole

Similarity: 0.87

Piperidines

Chemical Structure| 356072-46-3

[ 356072-46-3 ]

Spiro[indoline-3,4'-piperidin]-2-one hydrochloride

Similarity: 0.89

Chemical Structure| 79098-85-4

[ 79098-85-4 ]

3-(Piperidin-4-yl)indolin-2-one hydrochloride

Similarity: 0.89

Chemical Structure| 2044705-27-1

[ 2044705-27-1 ]

4-Phenyl-2,8-diazaspiro[4.5]decan-3-one hydrochloride

Similarity: 0.78

Chemical Structure| 1774904-83-4

[ 1774904-83-4 ]

6-Fluorospiro[indoline-3,4'-piperidin]-2-one hydrochloride

Similarity: 0.77

Chemical Structure| 474538-99-3

[ 474538-99-3 ]

1'-Benzylspiro[indoline-3,4'-piperidine]

Similarity: 0.77

Spiroes

Chemical Structure| 356072-46-3

[ 356072-46-3 ]

Spiro[indoline-3,4'-piperidin]-2-one hydrochloride

Similarity: 0.89

Chemical Structure| 13861-75-1

[ 13861-75-1 ]

Spiro[cyclopropane-1,3'-indolin]-2'-one

Similarity: 0.87

Chemical Structure| 1175358-24-3

[ 1175358-24-3 ]

1'H-Spiro[piperidine-4,3'-quinolin]-2'(4'H)-one hydrochloride

Similarity: 0.85

Chemical Structure| 304876-29-7

[ 304876-29-7 ]

2',3',5',6'-Tetrahydrospiro[indoline-3,4'-pyran]-2-one

Similarity: 0.79

Chemical Structure| 2044705-27-1

[ 2044705-27-1 ]

4-Phenyl-2,8-diazaspiro[4.5]decan-3-one hydrochloride

Similarity: 0.78

; ;